| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8789987 | Urologic Oncology: Seminars and Original Investigations | 2018 | 7 Pages |
Abstract
The frequency of UTUC in patients with NMIBC after BCG therapy is not negligible. Two independent predicting factors (intravesical recurrence and nonpapillary nonpedunculated at TURBT before BCG) were identified for UTUC. These results might be useful to predict UTUC after BCG therapy for NMIBC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Naotaka M.D., Ph.D., Hiroshi M.D., Ph.D., Atsushi M.D., Ph.D., Masahiro M.D., Ph.D., Naoki M.D., Ph.D., Hitoshi M.D., Ph.D., Noriomi M.D., Ph.D., Masanori M.D., Ph.D., Yasuharu M.D., Ph.D., Keisuke M.D., Ph.D., Hiroshi M.D., Ph.D., Naoya M.D., Ph.D.,